NCT01533207
Clinical Trial Information
Trial Number: NCT01533207 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Phase III Randomized Trial of Gemcitabine (NSC# 613327) Plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) Versus Observation for Uterus-Limited, High-Grade Uterine Leiomyosarcoma
Study ID:
GOG-0277
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01533207-D2 | This dataset contains AE data from PubMed 30289732. |
| NCT01533207-D1 | This dataset will allow users to reproduce the treatment comparison between Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin and Observation from PubMed 30289732. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®